Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19; and High Infection Risk of SARS-CoV-2”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Large-scale testing (Phase 3)Ended earlyNCT04913675
What this trial is testing

Intramuscular and Intravenous VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19.

Who this might be right for
Covid19
Vir Biotechnology, Inc. 1,065
Testing effectiveness (Phase 2)Ended earlyNCT05785390
What this trial is testing

Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.

Who this might be right for
COVID-19
Novatek Pharmaceuticals 170
Not applicableUnknownNCT05642910
What this trial is testing

The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled Trial

Who this might be right for
SARS-CoV-2 Infection
Southeast University, China 540
Large-scale testing (Phase 3)Looking for participantsNCT06679140
What this trial is testing

Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

Who this might be right for
COVID-19 SARS-CoV-2 Infection
Pfizer 2,330
Early research (Phase 1)UnknownNCT04441918
What this trial is testing

Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects

Who this might be right for
COVID-19; and High Infection Risk of SARS-CoV-2
Shanghai Junshi Bioscience Co., Ltd. 40
Early research (Phase 1)UnknownNCT05925140
What this trial is testing

LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19Hospitalized COVID-19 Patients
Lebanese University 1,000
Large-scale testing (Phase 3)Study completedNCT05629962
What this trial is testing

SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection)COVID-19
Atea Pharmaceuticals, Inc. 2,285
Early research (Phase 1)Ended earlyNCT05487040
What this trial is testing

Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Who this might be right for
COVID-19
Pfizer 15
Early research (Phase 1)Study completedNCT04869072
What this trial is testing

Convalescent Plasma Therapy - Zurich Protocol

Who this might be right for
COVID-19
University of Zurich 30
Large-scale testing (Phase 3)Looking for participantsNCT07743580
What this trial is testing

Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease

Who this might be right for
SARS-CoV-2
Shionogi 2,000
Large-scale testing (Phase 3)Study completedNCT04960202
What this trial is testing

EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19

Who this might be right for
COVID-19
Pfizer 2,091
Testing effectiveness (Phase 2)Study completedNCT04561063
What this trial is testing

COVID-19 Prophylaxis South Africa (COVER HCW)

Who this might be right for
Covid19SARS-CoV Infection
University of Witwatersrand, South Africa 1,950
Testing effectiveness (Phase 2)UnknownNCT05447013
What this trial is testing

Generation of SARS-CoV-2-specific T Lymphocytes From Recovered Donors and Administration to High-risk COVID-19 Patients

Who this might be right for
Severe COVID-19
George Papanicolaou Hospital 182
Large-scale testing (Phase 3)Ended earlyNCT04642638
What this trial is testing

Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure

Who this might be right for
Coronavirus InfectionSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)COVID-19 Disease
Inovio Pharmaceuticals 1,307
Testing effectiveness (Phase 2)Ended earlyNCT04992273
What this trial is testing

COVID-19 Administration of Single-Dose Subcutaneous Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of Age

Who this might be right for
COVID-19
Regeneron Pharmaceuticals 7
Not applicableStudy completedNCT05894499
What this trial is testing

Post-Marketing Safety Study in Japan of Shock and Anaphylaxis After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons in at High Risk of Severe COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 13,309
Not applicableStudy completedNCT05439044
What this trial is testing

A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB)

Who this might be right for
Immunocompromised Patients
Assistance Publique - Hôpitaux de Paris 4,235
Very early researchTemporarily pausedNCT06171152
What this trial is testing

Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

Who this might be right for
Multiple SclerosisLong COVIDLong Covid19+4 more
University of Chicago 30
Post-approval studies (Phase 4)Active Not RecruitingNCT07266558
What this trial is testing

Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 30,000
Not applicableUnknownNCT04353141
What this trial is testing

International Lung UltraSound Analysis (ILUSA) Study

Who this might be right for
COVIDPregnancy Complications, InfectiousPregnancy Related+5 more
KU Leuven 1,850
Next Page